| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.15 | 0.09 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |